Company Description
Insys Therapeutics can soothe your stomach and make the pain go away. The company focuses on developing drugs for treating nausea and vomiting...
Key Insys Therapeutics Financials
| Company Type | Private - NASDAQ (GM): INRX Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $0.0 |
| 2006 Employees | 17 |
More Insys Therapeutics Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Insys Therapeutics's competition across multiple industries
Top Insys Therapeutics Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Insys Therapeutics Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| VP Business Development and Strategic Alliances | Troy A. Ignelzi | Network | E-mail |
| President, CEO, and Director | Jon W. McGarity | Network | E-mail |
| EVP Technology | S. George Kottayil | Network | E-mail |
More Insys Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.